Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Bile Duct Neoplasms × Sorafenib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 16 Leukemia, Myeloid, Acute 7 Neoplasms 4 Liver Neoplasms 4 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Fibrolamellar hepatocellular carcinoma 2 Tongue Neoplasms 1 Thyroid cancer, Hurthle cell 1 Thyroid Diseases 1 Sarcoma, Myeloid 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors 1 Melanoma 1 Hepatoblastoma 1 Gastrointestinal Stromal Tumors 1 Desmoplastic Small Round Cell Tumor 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1 Brain Neoplasms 1

Interventions

Gemcitabine 9 Cisplatin 8 pembrolizumab 5 Oxaliplatin 4 Leucovorin 3 Fluorouracil 3 tivozanib 2 Magnetic Resonance Spectroscopy 2 Cholangiopancreatography, Endoscopic Retrograde 2 Capecitabine 2 zimberelimab 1 trametinib 1 tislelizumab 1 spartalizumab 1 seribantumab 1 quemliclustat 1 pertuzumab 1 irinotecan sucrosofate 1 durvalumab 1 derazantinib 1 atezolizumab 1 anlotinib 1 Tissue Adhesives 1 Tegafur 1 Specimen Handling 1 S 1 (combination) 1 Ritonavir 1 Radiosurgery 1 Radiofrequency Ablation 1 Photosensitizing Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡